Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 05 2021
Historique:
received: 29 10 2020
accepted: 23 03 2021
entrez: 12 5 2021
pubmed: 13 5 2021
medline: 2 6 2021
Statut: epublish

Résumé

Shigella sonnei is the most common agent of shigellosis in high-income countries, and causes a significant disease burden in low- and middle-income countries. Antimicrobial resistance is increasingly common in all settings. Whole genome sequencing (WGS) is increasingly utilised for S. sonnei outbreak investigation and surveillance, but comparison of data between studies and labs is challenging. Here, we present a genomic framework and genotyping scheme for S. sonnei to efficiently identify genotype and resistance determinants from WGS data. The scheme is implemented in the software package Mykrobe and tested on thousands of genomes. Applying this approach to analyse >4,000 S. sonnei isolates sequenced in public health labs in three countries identified several common genotypes associated with increased rates of ciprofloxacin resistance and azithromycin resistance, confirming intercontinental spread of highly-resistant S. sonnei clones and demonstrating the genomic framework can facilitate monitoring the spread of resistant clones, including those that have recently emerged, at local and global scales.

Identifiants

pubmed: 33976138
doi: 10.1038/s41467-021-22700-4
pii: 10.1038/s41467-021-22700-4
pmc: PMC8113504
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ciprofloxacin 5E8K9I0O4U
Azithromycin 83905-01-5

Banques de données

figshare
['10.6084/m9.figshare.13072646']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2684

Subventions

Organisme : Wellcome Trust
ID : A/106690/A/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R020787/1
Pays : United Kingdom

Références

Epidemiol Infect. 2020 May 04;148:e180
pubmed: 32364094
Front Microbiol. 2018 Mar 27;9:592
pubmed: 29636749
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Nat Commun. 2019 Oct 23;10(1):4828
pubmed: 31645551
PLoS Med. 2016 Aug 02;13(8):e1002055
pubmed: 27483136
Swiss Med Wkly. 2018 Aug 22;148:w14645
pubmed: 30141522
Nat Genet. 2012 Sep;44(9):1056-9
pubmed: 22863732
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
mSphere. 2016 Dec 21;1(6):
pubmed: 28028547
Emerg Infect Dis. 2016 Sep;22(9):1545-53
pubmed: 27532625
Bull World Health Organ. 1999;77(8):651-66
pubmed: 10516787
Genome Med. 2014 Nov 20;6(11):90
pubmed: 25422674
Emerg Infect Dis. 2016 Nov;22(11):1948-1952
pubmed: 27767929
N Engl J Med. 2019 Dec 19;381(25):2477-2479
pubmed: 31851807
Epidemiol Infect. 2013 Dec;141(12):2568-75
pubmed: 23425681
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32718957
Antimicrob Agents Chemother. 2003 Feb;47(2):727-34
pubmed: 12543684
Infect Control Hosp Epidemiol. 2019 Jun;40(6):649-655
pubmed: 31012399
PLoS Genet. 2020 Jul 9;16(7):e1008931
pubmed: 32644999
J Clin Microbiol. 2020 Mar 25;58(4):
pubmed: 31969425
Nucleic Acids Res. 2020 Jan 8;48(D1):D517-D525
pubmed: 31665441
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
Microb Genom. 2019 May;5(5):
pubmed: 31099740
Wellcome Open Res. 2019 Dec 2;4:191
pubmed: 32055708
Nat Commun. 2018 Apr 13;9(1):1462
pubmed: 29654279
Microb Genom. 2018 Mar;4(3):
pubmed: 29583113
Euro Surveill. 2019 May;24(22):
pubmed: 31164190
Clin Infect Dis. 2014 Oct;59(7):933-41
pubmed: 24958238
Lancet. 2018 Feb 24;391(10122):801-812
pubmed: 29254859
Microb Genom. 2015 Dec 24;1(6):e000042
pubmed: 28348825
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17522-7
pubmed: 24082120
Clin Infect Dis. 2019 Oct 15;69(9):1535-1544
pubmed: 30615105
Genome Res. 2020 Jan;30(1):138-152
pubmed: 31809257
Nucleic Acids Res. 2019 Jun 20;47(11):5539-5549
pubmed: 31076776
Lancet Infect Dis. 2015 Aug;15(8):913-21
pubmed: 25936611
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Clin Microbiol. 2002 Apr;40(4):1538-40
pubmed: 11923391
Clin Microbiol Infect. 2017 Nov;23(11):845-853
pubmed: 28389276
Foods. 2020 Aug 01;9(8):
pubmed: 32752159
Euro Surveill. 2019 Mar;24(13):
pubmed: 30940315
Sci Rep. 2018 May 9;8(1):7389
pubmed: 29743642
J Med Microbiol. 2020 Nov;69(11):1303-1307
pubmed: 33048044
Clin Infect Dis. 2016 Aug 1;63(3):380-6
pubmed: 27090985
J Antimicrob Chemother. 2017 Sep 1;72(9):2496-2502
pubmed: 28591819
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Commun. 2016 Oct 05;7:12827
pubmed: 27703135
Nucleic Acids Res. 2005 Nov 07;33(19):6445-58
pubmed: 16275786
Nat Commun. 2014 Nov 19;5:5471
pubmed: 25407023
BMC Infect Dis. 2009 Dec 15;9:204
pubmed: 20003464

Auteurs

Jane Hawkey (J)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia. jane.hawkey@monash.edu.

Kalani Paranagama (K)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.

Kate S Baker (KS)

Department of Clinical Infection, Microbiology, and Immunology, Institute for Infection, Ecological and Veterinary Sciences, University of Liverpool, Liverpool, UK.

Rebecca J Bengtsson (RJ)

Department of Clinical Infection, Microbiology, and Immunology, Institute for Infection, Ecological and Veterinary Sciences, University of Liverpool, Liverpool, UK.

François-Xavier Weill (FX)

Institut Pasteur, Unité des bactéries pathogènes entériques, Paris, France.

Nicholas R Thomson (NR)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Dept Infection Biology, London School of Hygiene & Tropical Medicine, London, UK.

Stephen Baker (S)

University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.

Louise Cerdeira (L)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.

Zamin Iqbal (Z)

European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, UK.

Martin Hunt (M)

European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, UK.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Danielle J Ingle (DJ)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Research School of Population Health, Australian National University, Canberra, ACT, Australia.

Timothy J Dallman (TJ)

National Infection Service, Public Health England, London, UK.

Claire Jenkins (C)

National Infection Service, Public Health England, London, UK.

Deborah A Williamson (DA)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Kathryn E Holt (KE)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Dept Infection Biology, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH